Question of the Day – Monday September 23, 2019
Question - What is the CompTox Chemicals Dashboard?
Question of the Day – Friday September 20, 2019
Question - What clinical manifestations occur following the ingestion of eucalyptus oil?
Question of the Day – Thursday September 19, 2019
Question - What is the effect of topical capsaicin on emergency department (ED) length of stay (LOS) for patients with cannabinoid hyperemesis syndrome (CHS)?
Question of the Day – Wednesday September 18, 2019
Question - In order to “provide Americans, including the most sensitive populations, with a margin of protection from a life-time of exposure to PFOA and PFOS from drinking water, EPA established the health advisory levels” for these chemicals. What is the current EPA health advisory level for these chemicals in drinking water?
Question of the Day – Tuesday September 17, 2019
Question - Alemtuzumab is a monoclonal antibody against cell surface antigen CD52 and is used to treat multiple sclerosis and chronic lymphocytic leukemia. What are the thyroid related adverse effects seen in patients taking Alemtuzumab?
Question of the Day – Monday September 16, 2019
Question - Domoic acid is an excitatory amino acid that can accumulate in certain shell and fin fish. Domoic acid is structurally similar to the neurotoxin kainic acid. Domoic acid and kainic acid are analogs to what important neurotransmitter?
Question of the Day – Friday September 13, 2019
Question - The article cited below notes “Neural-tube defects occur by the end of the sixth week of pregnancy (i.e. the fourth week after fertilization) and have been associated with exposure to specific drugs in pregnancy.” What newer antiretroviral agent (ARTs) has been posited to be associated with the development of neural-tube defects when used at the time of conception?
Question of the Day – Thursday September 12, 2019
Question - The article cited below notes “Immune thrombocytopenia (ITP) is an autoimmune disease characterized by isolated thrombocytopenia. Patients may be asymptomatic at presentation or they may present with mild mucocutaneous to life threatening bleeding”. Sudden onset of ITP has been reported after initiation of which medications?
Question of the Day – Wednesday September 11, 2019
Question - What is the phenomenon of so-called “endocrine disruption”?